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Abstract
Background:  A high prevalence of CAM use has been documented worldwide in children and
adolescents with chronic illnesses. Only a small number of studies, however, have been conducted in the
United Kingdom. The primary aim of this study was to examine the use of CAM by children and
adolescents with a wide spectrum of acute and chronic medical problems in a tertiary children's hospital
in Wales.
Methods: Structured personal interviews of 100 inpatients and 400 outpatients were conducted over a
2-month period in 2004. The yearly and monthly prevalence of CAM use were assessed and divided into
medicinal and non-medicinal therapies. This use was correlated with socio-demographic factors.
Results: There were 580 patients approached to attain 500 completed questionnaires. The use of at least
one type of CAM in the past year was 41% (95% CI 37–46%) and past month 26% (95% CI 23–30%). The
yearly prevalence of medicinal CAM was 38% and non-medicinal 12%. The users were more likely to have
parents that were tertiary educated (mother: OR = 2.3, 95%CI 1.6–3.3) and a higher family income
(Pearson chi-square for trend = 14.3, p < 0.001). The most common medicinal types of CAM were non-
prescribed vitamins and minerals (23%) and herbal therapies (10%). Aromatherapy (5%) and reflexology
(3%) were the most prevalent non-medicinal CAMs.
None of the inpatient medical records documented CAM use in the past month. Fifty-two percent of
medicinal and 38% of non-medicinal CAM users felt their doctor did not need to know about CAM use.
Sixty-six percent of CAM users did not disclose the fact to their doctor. Three percent of all participants
were using herbs and prescription medicines concurrently.
Conclusion: There is a high prevalence of CAM use in our study population. Paediatricians need to
ensure that they ask parents and older children about their CAM usage and advise caution with regard to
potential interactions.
CAM is a rapidly expanding industry that requires further evidence-based research to provide more 
information on the effectiveness and safety of many CAM therapies. Statutory or self-regulation of the 
different segments of the industry is important. Integration of CAM with allopathic western medicine 
through education and better communication is slowly progressing.
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Background
Definition
The use of complementary and alternative medicine
(CAM) by children and adolescents is something that all
health professionals involved in their care need to be
aware of. CAM can be defined as, "diagnosis, treatment
and/or prevention which complements mainstream med-
icine by contributing to a common whole, by satisfying a
demand not met by orthodoxy, or by diversifying the con-
ceptual frameworks of medicine" [1].
Prevalence studies
A high prevalence of CAM use is well documented in chil-
dren with a chronic illness, for example: oncology
patients 42%, juvenile rheumatoid arthritis 70% and
inflammatory bowel disease 72% [2-4]. Recent studies
recorded significant usage of CAM in community paediat-
rics; 32% of children newly diagnosed with autism; 54%
with behavioural problems and 56% in families of chil-
dren with cerebral palsy [5-7].
Reported prevalence of use in adults ranges between 9–
65% [8]. Fewer studies have been conducted in children,
but a systematic review in 1999 found 9–70% of them
used CAM. [9] More recent CAM studies in paediatric pri-
mary care showed a reported usage of 21–33 % [10,11]
and hospital based studies 12–53%[12-14]. This study
used the same methodology as a research team based at
the Royal Children's Hospital in Melbourne, Australia
[15]. Their study in 2002 found an overall yearly preva-
lence of CAM use of 51%.
Few surveys have been conducted in the UK, a study of
adult cancer patients in 2001 found a yearly prevalence of
CAM use of 49% [16]. A paediatric study by Simpson et al.
from 1996 study in the Bath area found a general paediat-
ric outpatient prevalence of 21% [17] and in a recent
Leeds study, use ranged between 12–62%, in a sample
which included healthy children and those with a chronic
illness [18]. In a population based childhood study CAM
use was 18% [19].
Expenditure
It is an expanding industry; in 2000 MacLennan et al.
repeated a 1993 representative population survey in
South Australia [20,21]. Extrapolation of expenditure in
2000 was AUS$2.3 billion in Australia and US$34 billion
in the U.S. population. In Australia this represented a 62%
increase and the expenditure on alternative therapies was
nearly four times the public contribution to all pharma-
ceuticals. There is little data on CAM expenditure in the
United Kingdom, in 1998 90% of CAM provision was
purchased privately with an annual out of pocket expend-
iture of approximately £450 million [22]. In 2003 it was
determined that £211 million was spent on herbal thera-
pies alone [23]. These figures are from adult based studies,
making it difficult to identify expenditure on children, but
it could be hypothesised that as family spending on CAM
increases a proportion of this will be for use by children
and adolescents.
Public health
The use of CAM in the community at large, including chil-
dren, is not just a clinical or hospital based issue. There are
far reaching public health implications as highlighted by
the House of Lords Report into CAM [24]. The American
Journal of Public Health devoted an entire issue to com-
plementary and alternative medicine in 2002 [25]. Espe-
cially important in children is the safety of CAM therapies,
their potential for interactions and regulation of the CAM
industry. The efficacy of these therapies is also a major
issue, which further evidence-based research needs to
address.
Methodological limitations
A major limitation of the few studies conducted into CAM
in children is the variable methodology and this study
aims to address some of these limitations. Ernst only
included only 10 of a possible 100 studies in a systematic
review because of these issues [9]. Some fundamental
problems with study design included the fact that most
used a self-administered questionnaire, which has signifi-
cant limitations, including problems of confusion of the
overall meaning of questions and misinterpretation of
individual terms or concepts that cannot be clarified. This
is particularly important in the CAM field where defini-
tion and clarification is so important. Self-administered
questionnaires may often be incomplete and have a
poorer response rate than an interview administered ques-
tionnaire. The size of previous studies has also been vari-
able, as has the country survey's have been conducted in.
This combined with a variable definition of CAM makes
direct comparisons difficult. The time frame of CAM use is
also often not clear, with many using 'lifetime prevalence',
that is CAM use at any point in the past. This is prone to
recall bias. A discussion on adverse effects was not men-
tioned in 70% of the papers reviewed and 90% of did not
clarify the cost of these therapies. The review was con-
ducted in 1998, but many of the problems outlined above
still exist, with surveys on CAM use in children often being
self-administered questionnaires and include lifetime
prevalences.
Aims
The primary aim was to examine the use of CAM by chil-
dren and adolescents in a tertiary children's hospital in
Wales. This included those with acute and chronic ill-
nesses. Secondary aims include: 1. Investigate association
of CAM usage with socio-demographic factors, 2. Ascer-
tain the frequency of CAM use, its cost and perceived help-BMC Complementary and Alternative Medicine 2006, 6:16 http://www.biomedcentral.com/1472-6882/6/16
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fulness, 3. Explore patients'/parents' knowledge regarding
the risks of side effects from CAM and their possible inter-
actions with other therapies, 4. Identify whether CAM use
is discussed with medical practitioners and whether inpa-
tient medical records showed any evidence of appropriate
documentation and 5. Examine the public health implica-
tions of CAM use
Methods
A cross-sectional survey of the use of CAM by children and
adolescents was undertaken from January to February
2004 at the University Hospital of Wales (UHW), Cardiff.
This is a tertiary paediatric centre with approximately
10,000 inpatients and 6,500 outpatients seen per year
(Allaway J, personal communication, 2005). The ques-
tionnaire was based on that used in an identical study at
the Royal Children's Hospital, Melbourne, Australia [15].
The sample population of 500 participants were divided
into 100 inpatients and 400 outpatients. The age range
was between 0–18 years. The outpatients were also in
groups of 100, namely: endocrinology, general paediat-
rics, gastroenterology and respiratory. These groups were
chosen to produce a broad cross-section of the tertiary
hospital population. The sample was obtained by inter-
viewing consecutive inpatient admissions and children
attending the relevant outpatient clinics over the study
period. None of the paediatricians caring for children at
UHW were practitioners of any form of CAM.
Data were collected in a structured interview-adminis-
tered questionnaire with the patient and/or parents/
guardian. It took approximately 10–15 minutes to com-
plete. There were four interviewers involved in the study
(NC, DC, AR & DW). Three of interviewers were paediatri-
cians in training and the fourth (DW) a pre-registration
pharmacist. All were calibrated prior to commencement
of the study, by discussing as a group questionnaire
administration and recording of data. The questionnaire
had been piloted in Melbourne and some of the difficul-
ties in administering the questionnaire were discussed
with their research team. The questions were predomi-
nantly of a closed nature with multiple categories, includ-
ing areas for comments. The interviewers were not
involved in the medical treatment of the patients and did
not enter into discussions regarding their personal opin-
ions about CAM. Any specific questions regarding thera-
pies were directed to their treating medical practitioner.
Exclusion criteria included insufficient knowledge of Eng-
lish and those children/adolescents admitted to intensive
care. Written consent was obtained prior to commencing
the interview. All patients/parents were given an informa-
tion sheet. The South East Wales Local Research and Eth-
ics Committee and the Research and Development
committee at UHW approved the study.
Definition
The type of CAM was divided into seven medicinal
(naturopathic, herbal, homeopathic, Traditional Chinese
medicine, health products, dietary and food supplements
or non-prescribed vitamins and minerals) and thirteen
non-medicinal (chiropractic, naturopathy, Traditional
Chinese therapies, acupuncture, aromatherapy, iridology,
therapeutic massage, reflexology, Buteyko breathing,
kinesiology, reiki, hypnosis, special exercises or modified
diet) therapies. There was also a free text area for CAM
therapies not included on the list. Use of these therapies
in the last year and past month was clarified. Non-pre-
scribed vitamins and minerals were included as a CAM
because a medical practitioner is not monitoring their use,
despite them being taken as a medicine with therapeutic
intent.
Statistical considerations
In determining the sample size a literature review was per-
formed to determine the expected frequency of CAM
usage. This was estimated to range between 10 –70%. [9]
A sample size of 100 for each group (500 subjects in total)
will estimate any proportion to within +/- 10%, or better,
with 95% confidence. This sample size is also identical to
that used in the in Melbourne study [15]. The data was
entered into a Microsoft Excel© database and analysed
using SPSS version 11.0©. Initial univariate analyses com-
pared users and non-users of CAM. Proportions were
compared using a Pearson chi-square test, with point esti-
mate and 95% confidence intervals determined and a 'p
value' of <0.05 considered statistically significant.
The data entry was checked by manually reviewing a com-
puter generated random 5 percent of the data set at com-
pletion of the study. The stability of the questionnaire was
reviewed by re-conducting the interview in a random 5
percent of respondents. This was done by telephone, 4–6
weeks after the initial interview. The interviewers were
also compared, looking at any differences in CAM disclo-
sure. Data has been collected and presented in an anony-
mous manner. All master copies of subject lists and
questionnaires were retained securely within the Depart-
ment of Paediatrics, UHW.
Results
Five hundred and eighty patients were approached to
complete 500 questionnaires. Five were excluded because
of insufficient English language skills and 39 were missed
because they left before being seen in busy clinics. Ten had
already been seen in previous clinics or as inpatients and
were therefore not re-interviewed. There were 23 who
refused or did not fully complete the survey and 3 who didBMC Complementary and Alternative Medicine 2006, 6:16 http://www.biomedcentral.com/1472-6882/6/16
Page 4 of 10
(page number not for citation purposes)
not have a legal guardian present. The interview was con-
ducted with the index case (adolescent) in 7% of cases and
their mother in 75%, father 17% and other guardian in
1%.
The study population of 500 interviewed was 52% male,
with a mean age of 8 years (standard deviation 5.1 years)
and a median of 7.8 years (range: 1 month to 19 years).
The family income was greater than £20,000 for 52% of
those studied. Tertiary education had been gained by 47%
of mothers and 48% of fathers. Sixteen percent of families
had private health cover that included cover of the index
case.
Table 1. outlines 1-yearly CAM usage. The yearly preva-
lence of using at least one CAM was 206 out of 500 or
41%. The point prevalence of all CAM use in the last
month was 26%. The prevalence of CAM use were very
similar in the inpatients and the four different outpatient
groups, except for being possibly slightly higher in the res-
piratory group (49%).
Table 2 outlines the socio-demographic factors associated
with CAM use. Those using CAM had a higher family
income and parental tertiary education. There were no dif-
ferences in CAM use with regards to gender, age, number
of children in the household or private health insurance.
The most commonly used types of CAM are outlined in
Figure 1. The most frequently used medicinal CAM were
non-prescribed vitamins and minerals and herbal thera-
pies. In non-medicinal CAM group aromatherapy and
reflexology were the most commonly used.
The use of prescription medications in the last month was
73% (358/493). The types of medications used were clas-
sified into the listed groups in Table 3. A total of 22%
(108/493) used medications from more than one group.
Five percent of participants had used herbal medicines in
the last month and of those 68% (17/25) were also using
a prescription medication. Thus 3% of participants overall
were using herbs and prescription medications concur-
rently. Only 13% (32/256) of respondents knew there was
the potential for interactions and of those, 56% (18/32)
could actually specify one. Of those using CAM 5% (9/
182) had experienced side effects. All of the side effects
described were of a minor nature. The knowledge of any
potential side effects of CAM was 15% (73/500) and 82 %
(60/73) of those could name one. None of the 23 inpa-
tients using CAM in the last month had this documented
in medical or nursing notes.
Expenditure is depicted in Figure 2. There is a trend
towards higher expenditure in non-medicinal CAM,
which had a higher median cost (£5–20 per month) than
medicinal CAM (£1–4 per month).
CAM was self- initiated (parent/participant/family/
friend) in 74%, with much lower initiation/recommenda-
Figure 1
Most common types of CAM used- medicinal and non-
medicinal (percentage of total participants).
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Table 1: 1-year Prevalence of Complementary and Alternative Medicine (CAM) Use
Group Prevalence (%) 95% Confidence Interval (%)
Any CAM Use (overall) 41 37–46
Medicinal CAM 38 34–42
Non-medicinal CAM 12 9–14
Both medicinal and non-medicinal CAM 8 6–10
Excluding vitamins and minerals 25 21–29
CAM >/= 3 times (of total participants) 36 32–41
Patient Group
Inpatients CAM use 39 30–49
Endocrine CAM Use 39 30–49
General Paediatric CAM Use 37 28–47
Gastroenterology CAM Use 42 33–52
Respiratory CAM Use 49 39–59BMC Complementary and Alternative Medicine 2006, 6:16 http://www.biomedcentral.com/1472-6882/6/16
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tion by doctors (6%) or CAM practitioners (14%), At least
one CAM was perceived as helpful by 57% (117/206) of
CAM users. The use of CAM was not disclosed to the med-
ical practitioner in 66% (135/206)of cases. 52%(97/185)
medicinal and 38% medicinal CAM as safe (19%), natural
(9%) and available over the counter (7%). Quotes
included: "Doctors don't have the time" or are "Not inter-
ested", "I wanted to tell the doctor but feel that they don't
want to hear", "doctors not bothered by colic", or the
"doctor is ignorant so would not be interested".
The four interviewers were compared with regards to dis-
closure of CAM use in the past year as shown in Table 4.
The random data check revealed a maximum error rate of
Table 2: Socio-demographic factors associated with CAM use
Variable CAM users/Total Percent % Pearson chi-square 
for trend (df = 1)
p value
Demographics
Age (yr)
<2 33/74 45
2 – 4 36/97 37
3 – 8 48/103 47
9 – 11 28/89 31
> 12 61/137 46 0.27 0.60
Household Income (£)
< 6000 8/37 22
6001 – 12000 16/53 30
12001 – 20000 45/109 41
20001 – 30000 35/94 37
> 30000 83/159 52 14.30 <0.001
No. of children in household
One 49/120 41
Two 89/205 43
Three 41/101 41
> Three 25/69 36 0.44 0.51
Variable CAM users/Total Percent% Odds Ratio (95% C.I.) p value
Sex
Male 113/259 44 c
Female 93/241 39 0.8 (0.6 – 1.1) 0.25
Country of birth (child)
UK 201/485 41 c
Overseas 4/13 31 0.6 (0.2 – 2.1) 0.44
Country of birth (mother)
UK 186/455 41 c
Overseas 18/42 43 1.1 (0.6 – 2.1) 0.80
Country of birth (father)
UK 179/440 41 c
Overseas 24/54 44 1.2 (0.7 – 2.1) 0.60
Post secondary education (mother)
No 84/260 32 c
Yes 120/231 52 2.3 (1.6 – 3.3) <0.001
Post secondary education (father)
No 92/249 37 c
Yes 109/234 47 1.5 (1.0 – 2.1) 0.03
Private Insurance
No 170/418 41 c
Yes 34/77 44 1.2 (0.7 – 1.9) 0.57
c = comparative groupBMC Complementary and Alternative Medicine 2006, 6:16 http://www.biomedcentral.com/1472-6882/6/16
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0.7% (95%CI 0.4–1.3%). The stability testing of the ques-
tionnaire showed a 3.3% (95%CI 2.5–4.4%) difference in
responses when the survey was re-conducted over the tel-
ephone.
Discussion
Prevalence
Our results with a yearly prevalence of 41% (95% confi-
dence interval (CI) 37–46%) is in the upper range com-
pared with studies worldwide [9]. Our general paediatric
subgroup used 37% (95%CI 28–47%), which is higher
than the general paediatric outpatient UK study in 1996
[17]. This may be a true increase in CAM use over that
time, but confounders include; differences in the two out-
patient populations, the definition of CAM used or the
fact that our study was interview led, rather than a self-
administered questionnaire, which may underestimate
use. There was no statistical difference in the prevalence
amongst the inpatient and outpatient groups with overlap
of the 95% confidence intervals (Table 1). All of the four
outpatients included patients with chronic illnesses and
the high number of cystic fibrosis patients in the respira-
tory outpatients may partially explain their slightly higher
prevalence. The prevalence in Cardiff is significantly lower
the prevalence found in the Melbourne study (51%, 95%
CI 47–56%) [15]. The reasons for this difference have
been explored in a separate comparative analysis between
the two tertiary centres [26].
Socio-demographic factors
Socio-demographic factors associated with CAM use were
parental tertiary education and high income. This sup-
ports the view that CAM is associated with higher socio-
economic status [12,14]. Higher levels of education may
lead to exposure to these therapies, especially given their
high profile in the media. The lack of other socio-demo-
graphic factors implicated in CAM use from our study sup-
ports many of the previous surveys [11,13,27].
Cost
Nearly two-thirds of medicinal CAM cost less than £5 per
month, with about one-third spent nothing per month.
This supports the assertion that CAM may not be as expen-
sive as is commonly believed, as concluded by a large
Canadian study which found that CAM was less than
CAN$20 in 37% of cases and more than CAN$60 in only
Table 4: CAM use disclosure by interviewer
Interviewer Occupation Number of CAM users/Total 
number interviewed
Percentage (95% confidence 
interval)
NC Paediatric Specialist Registrar 73 out of 210 35% (29 – 41%)
DC Paediatric Specialist Registrar 50 out of 127 39% (31 – 48%)
AR Paediatric Senior House Officer 46 out of 100 46% (37 – 56%)
DW Pharmacy student 37 out of 63 63% (46 – 70%)
Table 3: Use of prescription drugs in the past month. *Based on 
table by Madsen et al.[14] [N = 493]
n%
No drug use 135 27
Drugs against cardiac disease 8 2
Drugs against CNS disease (e.g. anticonvulsants) 22 5
Anti-neoplastic drugs (prednisolone, immunosuppressive 
drugs, folic acid)
36 7
Drugs against GI disease 71 14
Insulin or other hormones 71 14
Antibiotics and other systemic drugs against infectious 
diseases
99 20
Drugs for asthma, eczema, allergy 103 21
Other: Over the counter (OTC), paracetamol nutritional 
supplements/vitamins on doctors prescription
77 16
Figure 2
Expenditure on CAM (£ per month).
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6% [27]. A BBC commissioned survey in 1999 of CAM use
amongst adults in the United Kingdom approximated
CAM expenditure of £14 per month with about one-third
spending less than £5 per month [28]. Non-medicinal
CAM tended to be more costly as seen in this study, with
about one-third spending more than £20 per month and
13% spending more than £40. This may limit their avail-
ability and therefore prevalence, which was significantly
less than medicinal forms of CAM (12%. versus 41%). Of
note some non-medicinal therapies were 'free' because
treatments such as therapeutic massage or reiki were pro-
vided at no cost by friends or relatives.
Disclosure
Disclosure of CAM use to medical practitioners is impor-
tant if the issue is to be discussed and any potential inter-
actions or adverse effects detected. In our study 66% did
not disclose CAM usage to their doctor, which is similar to
previous studies [15,18,29]. Reasons for lack of disclosure
may reflect a perceived lack of acceptance by the physi-
cian. It is important part of doctor-patient communica-
tion that issues such as CAM is discussed in a
nonjudgmental and open manner. The "don't ask, don't
tell" status quo, [29] is also reflected in the fact that there
was no documentation of recent CAM use in the inpatient
notes. Poor communication is supported by other studies,
which found few doctors (16%) ask about CAM use [30].
In a study of paediatricians and nurses attitudes to CAM,
many using CAM themselves, but only 40% actually asked
about CAM [31]. The main reason given for not discussing
these therapies was a lack of confidence to do so because
of minimal education about these therapies and the lim-
ited safety and efficacy data available.
Efficacy and perceptions
A review of 19 surveys between 1982 to 1995, looking
into the referral patterns of physicians to CAM practition-
ers, highlighted the fact that decisions need to be based on
efficacy studies, rather than "regional economics and cul-
tural norms", and "somewhere between over enthusiastic
belief and stubborn disbelief is a balanced perspective
that will help patients and advance medical science" [32].
The perception of parents and adolescents of doctors as
not being interested was commonly found in this study,
with quotes including: "they were not interested", "did
not have the time" or "wanted to tell the doctor but feel
that they don't want to hear".
Integrative medicine
Integrative medicine refers to "looking at a broad range of
therapies and considering those that have the best evi-
dence of safety and effectiveness in the context of holistic
care". [33] It has been strongly supported by The Prince of
Wales's Foundation for Integrated Health [34] and is
becoming an important component of medical educa-
tion. Cohen provides a practical example of integrative
care, focusing on the chronically ill, "as many of these
patients could benefit from the services of CAM practi-
tioners... and as evidence emerges that some CAM are
effective then it becomes ethically impossible for the med-
ical profession to ignore them". [35] Studies have found
that CAM practitioners are keen on integration. [36]
Safety
One of the major concerns for medical practitioners
regarding CAM use is safety. Despite popular belief, CAM
is not always "natural" and "safe" or free of side effects,
and there are many case reports of adverse events in chil-
dren. These include: death, neurological disability, organ
failure and organ puncture[37]. Possible interactions
between medicinal CAM, particularly herbal remedies
and prescription medications, is well documented [38].
When questioned the majority (87%) of adolescents or
parents in this study could not name a potential interac-
tion. It was determined that there was a 3% risk of a par-
ticipant in the study concurrently taking a herb and
prescription medication. This is quite a small number in
our hospital-based population and may mean that the
interaction potential is less than previously believed. All
ingested therapies, however, have the potential to interact
so communication and reporting of interactions remains
very important. Up-to-date information about CAM is
becoming more available with pharmacists, local drug
advisory services and some Internet resources useful
[39,40].
Evidence-based medicine
Funding is a major issue for producing quality evidence-
based research into CAM as resources are still allocated
predominantly through traditional biomedical channels
and in 1996 only 0.08% of funding in medical sciences
was going into CAM [41]. As stated by Ernst; "The scien-
tific establishment criticises the paucity of data and weak-
ness of CAM hypotheses with one breath and with their
next breath they withhold the money that would be essen-
tial for changing this situation" [42].
Regulation
Following the House of Lords Science and Technology
Committee report on CAM in 2000, there was a push for
some CAM practitioners such as Osteopaths and Chiro-
practors to follow the medical model of statutory regula-
tion as seen with the General Medical Council [24].
Alternatives to statutory regulation are self regulation,
with development of national standards regarding train-
ing and competence. Welsh et al. looked in depth at the
tensions and difficulties in CAM practitioners seeking self-
regulation [43]. The Prince of Wales's Foundation for Inte-BMC Complementary and Alternative Medicine 2006, 6:16 http://www.biomedcentral.com/1472-6882/6/16
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grated Health has also played an important role in this
area [34].
All professions are prone to rogue practitioners, such as
those outlined in the study of Traditional Chinese thera-
pists treating atopic eczema with topical remedies that
were shown on analysis to contain high levels of poten-
tially hazardous steroids [44]. In these situations it is
important that the public sees effective and visible disci-
plinary procedures.
Limitations of this study
There were a number of potential areas of bias in this
study, namely: 1. Questionnaire 2. Interviewer, 3. Inter-
viewee, 4. Sampling, 5. Language bias. The questionnaire
itself may have produce bias towards the listed agents as it
is not possible to include all CAM therapies and there was
a free text area. This was minimised by extensive review of
the literature and including 7 medicinal and 13 non-
medicinal therapies in the interview led questionnaire. Of
note 5 of the 20 therapies accounted for the majority of
CAM use, with some CAM only being used by less than
2% of the study population.
Despite calibrating the interviewers with a view to obtain-
ing consistent responses, it remains possible that incon-
sistencies in asking questions and recording answers
occurred The interviewers [NC, DC, AH, DR] had variable
amounts of CAM disclosed (Table 4) and in particular
CAM use was much higher (63%) in the surveys con-
ducted by DW. He was a pharmacy student whilst the
other three interviewers were paediatric trainees. All inter-
viewers were similarly attired, with no identifying fea-
tures. DW interviewed only a small proportion of
participants (13%).and none of the inpatient subgroup.
DW may have had higher CAM disclosure because as the
only pharmacist amongst the interviewers he may have
been better at gaining information about medication use
and CAM. Alternatively there could have been some
potential bias in the parents/patients perceptions of the
different interviewers, thus affecting disclosure. In partic-
ular, the role of the three doctors as interviewers may have
led participants to feel that they would not approve of
CAM use. This would produce an under-estimate of CAM
use in our population. The fact that the interviews were
conducted in a busy outpatient clinic and on the inpatient
wards may have inhibited disclosure of CAM use in some
cases.
Different responses may also be obtained when interview-
ing the patient or either parent about CAM. The knowl-
edge and opinions regarding CAM may differ within the
family. The mother (75%) was the person most com-
monly interviewed in the survey. The prevalence may be
under-estimated in cases where a guardian with less
knowledge about the child completed the questionnaire.
This study asked about CAM use in the past year, which is
prone to recall bias, as participants may find it difficult to
remember exactly what therapies were used. Repeating the
questionnaire over the phone showed that it had stability
with only a 3.3% difference in responses. There was, how-
ever, no differentiation made between positive or negative
differences and individuals may have started or stopped
taking CAM in the two months between the two surveys.
It is also possible that respondents were more educated
about CAM after becoming involved in the study, affect-
ing the responses in the repeat questionnaire.
A representative sample is difficult to obtain, but by
approaching consecutive inpatient admissions and outpa-
tient presentations, the potential for sampling bias was
minimised. Only 80 cases were excluded and 10 of those
were because they had been interviewed previously. Infor-
mation was not obtained to directly compare the demo-
graphics or other details of the 80 excluded cases from the
500 respondents.
This study excluded a small number of subjects (5 in total)
who had insufficient knowledge of English, leading to
language bias. Whilst this is a small number overall, it
may be expected from the literature and on general prin-
ciples that this group is more likely to use CAM. Cost was
a factor as this study was not funded and there were insuf-
ficient resources to provide questionnaires in different
languages or provide independent interpreters. This study
was also designed with the aim of doing a direct compar-
ison of CAM use between Cardiff and Melbourne, so their
methodology was replicated, including exclusion of those
with insufficient English language skills. Whilst this
strengthens the comparability of data it highlights the
need for further research into specific ethnic groups and
CAM subtypes utilised by them.
Applicability of the study
As outlined previously methodologies used in CAM sur-
veys vary, reducing the comparability of studies and hence
the applicability of our study elsewhere. The study popu-
lation was a tertiary paediatric group based at one loca-
tion, comprising children with acute and chronic
illnesses. The results whilst not applicable to the general
population, may apply to other tertiary paediatric centres
with similar demographics and case-mix. Well-conducted
population based studies are require to ascertain the over-
all use of these therapies in children.
Conclusion
This study confirms a high prevalence of use in our tertiary
paediatric population. CAM cannot be ignored and med-
ical practitioners need to be better educated about these
therapies. As stated by Coulter, "CAM is here to stay andBMC Complementary and Alternative Medicine 2006, 6:16 http://www.biomedcentral.com/1472-6882/6/16
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will continue to present challenges for conventional med-
icine of how to respond"[45]. Paediatricians need to spe-
cifically ask about CAM use and document this
appropriately. It should be discussed with patients in an
open, non-judgemental way. In particular patients and
medical practitioners should be aware of potential inter-
actions and liaise with their pharmacy or drug advisory
department if required. This will help patients and their
parents make more informed, safe choices. Further evi-
dence-based studies are required to provide more infor-
mation on the effectiveness and safety of many CAM
therapies [46]. The public health implications of CAM are
far reaching and include regulation of the industry and
protection of the public through appropriate safety and
monitoring measures. Integrative medicine is slowly pro-
gressing bringing together western allopathic medicine
and CAM therapists through improved communication
and education.
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